Company intelligence / Profile preview
Dalkhimpharm
Vladivostok, Primorsky Krai, Russia
- Ownership
- Private
- Development stage
- Other
01
Overview
Dalkhimpharm is a top Russian pharmaceutical manufacturer, focusing on finished pharmaceutical products including both standard generics and herbal medicines. The company is active and well-established in both Russian national and select international markets, with products spanning oral and topical forms; there is no public evidence of proprietary new chemical entity clinical trials.
- Therapeutic areas
- Other
- Modalities
- Small moleculeHerbal extractBiologic (possible, based on product list including tinctures and extracts)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Dalkhimpharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dalkhimpharm.